The Largest Security-Cleared Career Network for Defense and Intelligence Jobs - JOIN NOW

Homeland Security

Russia's COVID Vaccine Sputnik V Green-Lighted for Use in Angola, Congo, Djibouti

Sputnik News

13:33 GMT 03.03.2021(updated 13:50 GMT 03.03.2021)

MOSCOW (Sputnik) - Angola, Djibouti and the Republic of Congo have officially authorized Russia's coronavirus vaccine Sputnik V for mass use, the Russian Direct Investment Fund (RDIF) said on Wednesday.

"The Russian Direct Investment Fund ... announces the approval of the Russian Sputnik V vaccine against coronavirus by regulatory authorities of the Republic of Angola, Republic of Congo and Republic of Djibouti. Sputnik V has been registered under the emergency use authorization procedure," the RDIF said in a statement.

The Russian vaccine has now been approved for emergency use in 42 countries across the world.

In February, peer-reviewed medical journal The Lancet published an interim analysis from Phase III clinical trial of the Russian vaccine, showing its 91.6-percent efficacy against symptomatic COVID-19.

Developed by the Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V was the world's first officially-registered vaccine against COVID-19.

© Sputnik



NEWSLETTER
Join the GlobalSecurity.org mailing list